Lee Sang-hoon

Early Life and Education

Lee Sang-hoon was born in South Korea in January 1963. He pursued his passion for biology, earning a Bachelor of Science and a Master's degree in developmental biology from Seoul National University between 1982 and 1989. In 1994, he completed a Ph.D. in Molecular, Cellular and Developmental Biology at the Ohio State University. Lee furthered his academic journey with postdoctoral fellowships at prestigious institutions like Harvard Medical School, University of California, San Francisco, and Stanford Medical School.

Rise to Success

Lee's career began with research roles at several prominent companies, including AstraZeneca, Genentech, and Exelixis. In 2008, he co-founded PharmAbcine. He then served as head of the biotech division at Hanwha Solutions. A pivotal moment came in 2016 when Lee founded ABL Bio. The company's listing on the KOSDAQ in 2018 marked a significant milestone. Lee achieved billionaire status in 2025 after ABL Bio signed a lucrative licensing and research deal with Eli Lilly.

Key Business Strategies

ABL Bio focuses on developing bispecific antibodies, designed to target two molecules simultaneously for improved treatment outcomes in cancer and neurodegenerative diseases. The company's strategy involves diversifying its portfolio of bispecific antibody-based treatments. A key deal with Eli Lilly, valued at $2.6 billion, highlights ABL Bio's success in technology transfer and collaborative research.

Philanthropy

Specific philanthropy amounts for Lee Sang-hoon were not found in the search results. However, the search results show that other people with the same name have participated in philanthropy.